Bio-Rad Laboratories (BIO-B) Current Leases (2019 - 2026)

Bio-Rad Laboratories (BIO-B) has 8 years of Current Leases data on file, last reported at $36.2 million in Q1 2026.

• Current Leases for Q1 2026 came in at $36.2 million, down 12.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $36.2 million (down 12.35% YoY), and the FY2025 annual result was $36.1 million, down 13.43% from the prior year.
• Current Leases held at $36.2 million in Q1 2026 per BIO-B's latest filing, from $36.1 million in the prior quarter.
• Over five years, Current Leases peaked at $42.8 million in Q3 2024 and troughed at $34.0 million in Q3 2022.
• A 5-year average of $38.3 million and a median of $36.8 million in 2025 frame the typical range for Current Leases.
• The sharpest annual moves came in 2023 and 2025: Current Leases gained 14.85% in 2023, then fell 14.02% in 2025.
• A 5-year view of Current Leases shows it stood at $36.3 million in 2022, then climbed by 11.18% to $40.4 million in 2023, then rose by 3.22% to $41.7 million in 2024, then decreased by 13.43% to $36.1 million in 2025, then climbed by 0.28% to $36.2 million in 2026.
• Business Quant data shows BIO-B's Current Leases at $36.2 million in Q1 2026, $36.1 million in Q4 2025, and $36.8 million in Q3 2025.